| Literature DB >> 24958932 |
Raquel N Carvalho1, Augustine Arukwe2, Selim Ait-Aissa3, Anne Bado-Nilles4, Stefania Balzamo5, Anders Baun6, Shimshon Belkin7, Ludek Blaha8, François Brion3, Daniela Conti5, Nicolas Creusot3, Yona Essig9, Valentina E V Ferrero1, Vesna Flander-Putrle10, Maria Fürhacker11, Regina Grillari-Voglauer11, Christer Hogstrand12, Adam Jonáš8, Joubert B Kharlyngdoh13, Robert Loos1, Anne-Katrine Lundebye14, Carina Modig13, Per-Erik Olsson13, Smitha Pillai11, Natasa Polak9, Monica Potalivo5, Wilfried Sanchez3, Andrea Schifferli15, Kristin Schirmer16, Susanna Sforzini17, Stephen R Stürzenbaum9, Liv Søfteland14, Valentina Turk10, Aldo Viarengo17, Inge Werner15, Sharon Yagur-Kroll7, Radka Zounková8, Teresa Lettieri18.
Abstract
The risk posed by complex chemical mixtures in the environment to wildlife and humans is increasingly debated, but has been rarely tested under environmentally relevant scenarios. To address this issue, two mixtures of 14 or 19 substances of concern (pesticides, pharmaceuticals, heavy metals, polyaromatic hydrocarbons, a surfactant, and a plasticizer), each present at its safety limit concentration imposed by the European legislation, were prepared and tested for their toxic effects. The effects of the mixtures were assessed in 35 bioassays, based on 11 organisms representing different trophic levels. A consortium of 16 laboratories was involved in performing the bioassays. The mixtures elicited quantifiable toxic effects on some of the test systems employed, including i) changes in marine microbial composition, ii) microalgae toxicity, iii) immobilization in the crustacean Daphnia magna, iv) fish embryo toxicity, v) impaired frog embryo development, and vi) increased expression on oxidative stress-linked reporter genes. Estrogenic activity close to regulatory safety limit concentrations was uncovered by receptor-binding assays. The results highlight the need of precautionary actions on the assessment of chemical mixtures even in cases where individual toxicants are present at seemingly harmless concentrations.Entities:
Keywords: bioassays; biomarkers; ecotoxicology; effects; mixtures
Mesh:
Substances:
Year: 2014 PMID: 24958932 PMCID: PMC4166171 DOI: 10.1093/toxsci/kfu118
Source DB: PubMed Journal: Toxicol Sci ISSN: 1096-0929 Impact factor: 4.849
Composition of Chemicals in the Reference Mixtures
| Substances | CAS | Use | Mode of action/reported effects | AA-EQS (μg/l) |
|---|---|---|---|---|
| Atrazine | 1912-24-9 | Herbicide | Photosystem II inhibitor | 0.6 |
| Benzo[a]pyrene (BaP) | 50-32-8 | By-product of incomplete combustion of organic material | Intercalation of BaP metabolites in DNA causing mutagenesis, carcinogenesis | 0.00017 |
| Cadmium | 7440-43-9 | Industrial by-product; used in metal plating and to make pigments, batteries, and plastics. | Indirect formation of reactive oxygen species, depletion of glutathione, lipid peroxidation | 0.08 |
| Chlorfenvinphos | 470-90-6 | Insecticide | Inhibition of cholinesterase activity | 0.1 |
| Chlorpyrifos | 2921-88-2 | Insecticide | Inhibition of cholinesterase activity | 0.03 |
| DEHP | 117-81-7 | Plasticizer | DNA damage, carcinogenicity | 1.3 |
| Diclofenac | 15307-79-6 | Pharmaceutical pain killer; non-steroidal anti-inflammatory drug (NSAID) | Can cause adverse hepatic effects in certain organisms | 0.1 |
| Diuron | 330-54-1 | Herbicide | Photosystem II inhibitor | 0.2 |
| 17β-estradiol | 50-28-2 | Natural estrogen | Natural estrogen | 0.0004 |
| Fluoranthene | 206-44-0 | Product of incomplete combustion | Causes mutagenesis, carcinogenesis | 0.0063 |
| Isoproturon | 34123-59-6 | Herbicide | Photosystem II inhibitor | 0.3 |
| Ni | 7440-02-0 | Industry, preparation of alloys | Depletion of glutathione levels, binds to sulfhydryl groups of proteins, carcinogenicity | 4 |
| 4-nonylphenol | 25154-52-3 | Mostly used for the production of surfactants (nonylphenolethoxylates) | Endocrine disruptor | 0.3 |
| Simazine | 122-34-9 | Herbicide | Photosystem II inhibitor | 1 |
| Carbamazepine | 298-46-4 | Pharmaceutical (anti-epileptic, mood-stabilizing drug) | Teratogenicity | 0.5 |
| Sulfamethoxazole | 723-46-6 | Pharmaceutical (antibiotic) | Interferes with folic acid synthesis | 0.6 |
| Triclosan | 3380-34-5 | Anti-bacterial and antifungal agent used in cosmetics and detergents | Inhibition of cellular efflux pumps | 0.02 |
| N,N-diethyl-m-toluamide (DEET) | 134-62-3 | Insect repellent | Affects insect odorant receptors, inhibits cholinesterase activity (nervous system) | 41 |
| Bisphenol A | 80-05-7 | Plasticizer | ER agonist | 1.5 |
Used only in Mix19 (in addition to the other chemicals also present in Mix14).
Chemical Abstracts Service.
According to European Directive 2013/39/EU.
Taken from COM 2011-876.
Proposal from Ecotox Centre, Switzerland.
Summary of Bioassays, Results, and Partner Laboratories in the EU-Wide Exercise
| Organism/test | Biological endpoint | Exposure | Effects | EC50 (×EQS) | Comments |
|---|---|---|---|---|---|
| Microcosmos in marine water | Bacteria production and pigment concentration | 6, 12, 24, 48 h | Increase in bacterioplankton decrease in phytoplankton | - | pH adjusted |
| Inhibition bioluminescence | 15, 30 min | No toxicity effect, stimulation of luminescence | - | pH adjusted | |
| Induction of biomarkers | up to 800 min | Mix14: | - | - | |
| Mix19: | |||||
| Growth inhibition | 24 h | Effect observed <10×EQS | 105 (Mix14) | 72, 96 h tested in some labs | |
| ISO 8692 | 116 (Mix19) | ||||
| Inhibition of photosynthesis (PSII) | 2 h | Effect observed <10×EQS | 7.3 (Mix14) | - | |
| 12.6 (Mix19) | |||||
| Growth inhibition | 24, 48, 72 h | Effect observed <10×EQS | 56 (Mix14) | Mix19 tested only at 1×EQS | |
| Inhibition of photosynthesis (PSII) | 2, 24 h | Effect observed <10×EQS | 19.2 (Mix14) | ||
| Growth inhibition | 24, 48, 72 h | Effect observed <10×EQS | 28 (Mix14) | Mix19 tested only up to 2×EQS | |
| Growth | 8 h | No effect | - | - | |
| Genotoxicity | 8 h | No effect | - | - | |
| Acute toxicity | 4 h | Acute toxicity significant ( | - | - | |
| (Transgenic fluorescent) | |||||
| Acute immobilization | 24, 48 h | Effect observed | 7 (24 h) | Mix19 tested up to 2×EQS | |
| EN ISO 6341 | <10×EQS (Mix14) | 3.4 (48 h) | |||
| Reproduction test | 21 days | 100% mortality after 3 days at 10×EQS (Mix14) | - | No effect at 1×EQS with respect to SC | |
| CSN ISO 10706 | |||||
| Growth | 120 h | Effect in development for Mix19 (1×EQS) | - | Growth uniform between exposures until 72 h, deviating after 96 h | |
| Lipid accumulation | 48 h | Increased accumulation of lipids in storage compartments (Mix14 10×EQS) | - | Mix19 tested only at 1×EQS | |
| Pharyngeal pumping | 48, 72 h | No effect on food intake (pharyngeal pumping) | - | - | |
| Movement | 48, 72, 96 h | No significant trends in movement | - | - | |
| Induction of several stress response proteins | 48 h | Mix19 (1×EQS) induced expression of gst-38, involved in phase II detoxification | - | No effect on mtl-2, ugt-, gcs-1, and Cyp-35a2- | |
| Dual-fluorescent transgenic organisms | |||||
| FET | 120 h | Malformations observed for Mix14 (10×EQS) and Mix19 (1×EQS) | - | Mix14 (1×EQS) no effect | |
| FET (EN ISO 15088) | |||||
| Frog embryo teratogenicity, embryo malformation | 96 h | Mix14 (10×EQS): 62 ± 10%; | - | 15 ± 12% malformed embryos in SC | |
| FETAX | Mix14 (1×EQS): 43 ± 12%; | ||||
| ASTM E 1439-98 | Mix19 (1×EQS): 34 ± 14% | ||||
| No effect on embryo length | |||||
| Lysosomal membrane stability | 3 h | Effects statistically not different from the solvent | - | - | |
| Replication | 24 h | No effect | - | - | |
| Leucocyte distribution | 18 h | No effect on any of the endpoints tested | - | - | |
| (Three-spined stickleback) | Cellular mortality | ||||
| Respiratory burst | |||||
| Lysosomal membrane integrity | |||||
| Phagocytosis activity | |||||
| MTT assay, cell lines: RTG-2 | 72 h | No effect | - | - | |
| 20 h | No effect | - | - | ||
| No effect | - | - | |||
| RPTEC/TERT1, HepG2, MCF7 | |||||
| HUVEC/TERT | |||||
| Neutral red test | Acute cytotoxicity | No effect | - | - | |
| H4IIE-luc cells | |||||
| xCELLigence Primary hepatocytes cultures, juvenile Atlantic salmon ( | Cytotoxicity system | up to 120 min | No effect | - | - |
| Atlantic salmon ( | ELISA (Vtg, Zrp regulation) | 5 days | No effect | - | Maximum concentration tested was 0.16 EQS |
| qRT-PCR (Vtg, ERα, Zrp) | 5 days | No effect | - | ||
| Regulation biomarkers | |||||
| HeLa, LMH, ZFL cells | Gene expression | 24, 40 h | HeLa: regulation of MT2A, AR, p53, GSTK1, IL6, IL8 | - | No effect ZFL cells |
| LMH: regulation of IL8 | |||||
| YES | ER-binding activity | 72 h | Activity measured for Mix14 and Mix19 | 92.3 (Mix14) | - |
| 90.5 (Mix19) | |||||
| ER-CALUX | 24 h | Activity measured for Mix14 and Mix19 | 4.9 (Mix14) | - | |
| 4.7 (Mix19) | |||||
| ER-activated luciferase induction | 18 h | Activity measured for Mix14 and Mix19 | 34.2 (Mix14) | - | |
| MELN cells | 13.3 (Mix19) | ||||
| wtERαLBD binding assay | 2 h | Binding measured for Mix14 and Mix19 | IC50 74.9 (Mix14) | - | |
| IC50 7.8 (Mix19) | |||||
| EASZY, i | 96 h | Activity measured for Mix14 above 4×EQS | - | - | |
| PLHC-1 cells | Dioxin-like activity | 24 h | No effect | - | - |
| EROD induction | |||||
| AR-CALUX | AR-binding activity | 24 h | No effect | - | - |
| AR-activated luciferase induction | 18 h | No effect | - | - | |
| MDA-kb2 cells | |||||
| PPAR-CALUX | PPAR γ2-like activity | 24 h | No effect | - | - |
| PXR-activated luciferase induction, HG5LN-PXR cells | PXR-binding activity | 18 h | Effect >10×EQS | - | - |
All tested reporter genes are detailed in Supplementary table 2.
All tested reporter genes are detailed in Supplementary table 3.
FIG. 1.Marine microcosm. Effect of the chemical mixtures on the natural phytoplankton and bacterioplankton community. Endpoints measured were bacterial production (a), chlorophyll a concentration (b), and other phytoplankton pigments (c). For comparison, identical SW samples have been left untreated (SW) or were exposed to SC. Error bars represent the standard deviation (n = 3).
FIG. 2.Cytotoxicity to microalgae. Dose response curves of Mix14 were generated for the inhibition of photosynthesis after 2-h exposure (a) and inhibition of growth after 24-h exposure (b) of the freshwater microalgae P. subcapitata and C. reinhardtii and the growth of marine diatom T. pseudonana. The x-axis is displayed as concentration of Mix14, in terms of EQS. The EC10 and EC50 values obtained from the fit of the data are shown for each of the endpoints. No effect from exposure to the solvent was observed for any of the organisms. Error bars represent the standard deviation, n = 3.
FIG. 3.Acute immobilization in D. magna. (a) Dose response of Mix14 in EQS equivalent concentrations, for immobilization at 24-h exposure (open symbols) and 48-h exposure (closed symbols). The lines represent the fit of non-linear regression model to the data for the calculation of the EC50. Error bars represent the standard deviation, n = 4. (b) Combined immobilization data from three different laboratories for Mix14 (at 1× and 10×EQS) and Mix19 (at 10×EQS).
Effect of Mixtures on the FET Test with Zebrafish and the FETAX
| Time | Endpoint | Chemical mixture | |||
|---|---|---|---|---|---|
| Mix14 10×EQS | Mix14 1×EQS | Mix19 1×EQS | |||
| FET | 72 h | Number of defected embryos | a | - | - |
| 96 h | Number of hatched embryos | a | - | - | |
| 120 h | Number of defected embryos | a, c | - | a | |
| Head deformities | a | - | - | ||
| Absence of gas bladder | a | - | - | ||
| Underdeveloped embryos | a | - | a, c | ||
| FETAX | 96 h | Total number of malformed embryos | a | a | a |
| Incomplete gut coiling | a | - | a | ||
| Tail malformation | a | - | a | ||
a: endpoint significantly different from SC (chi-square test, p < 0.05); c: endpoint significantly different from SC (ANOVA followed by Fisher LSD post hoc test).
FIG. 4.Embryos of Danio rerio from the FET (a)–(c) and Xenopus laevis from FETAX (d). (a) Control fish embryo 120-h post fertilization. (b) Embryo exposed to Mix14 at 10×EQS for 120 h - typical underdeveloped (smaller) embryo with non-inflated gas (swimming) bladder (G), deformed head especially at the mouth region (M), and not fully consumed yolk (Y). (c) Embryo from the same exposure as in panel (b) with highlighted deformation nearby the anal region (D), non-inflated gas bladder (G), and not fully consumed yolk (Y). (d) Control 96-h embryo of X. laevis (upper individual) compared with underdeveloped and malformed embryo exposed for 96 h to MIX19 1xEQS (the arrow shows the incomplete intestine coiling, which was the most frequent malformation observed).
FIG. 5.Estrogenic activity measurement using in vitro bioassays. Dose-dependent estrogenic activity of Mix14 and Mix19 was measured via ER-activated luminescence induction using the ER-CALUX and the MELN system, the β-galactosidase activity using the YES test, and the competition assay using the recombinant wtERαLBD. The EC50 values are shown, calculated from the fit to the data measured with the two mixtures and of E2 in the test, as well as the estimated and experimental EEQ concentrations. The error bars represent the standard deviation, n = 3.
FIG. 6.In vivo estrogenic activity of Mix14 as shown by induction of GFP in 96-hpf-old transgenic cyp191ab-GFP zebrafish larvae. Exposure was done at different concentrations of Mix14, during 96 h from fertilization, under static condition, after which fluorescence imaging on living zebrafish was performed. GFP was expressed in various brain regions in radial glial cells. Dorsal view, magnification X10, Tel: telencephal; Poa: preoptic area; Hyp: inferior lobe of hypothalamus. EE2 50pM was used as positive control. The mean fluorescent intensity is shown in the graph, indicating the number of larvae imaged for each condition (n), ***p < 0.001. EE2 led to a 26-fold induction.